Skip to main content
. 2020 Sep 6;8(9):333. doi: 10.3390/biomedicines8090333

Figure 1.

Figure 1

Impact of withanolides in reducing cell viability and proliferation of acute myeloid leukemia (AML) cell models. Percentage of viable cells and number of cells relative to control was determined as a function of treatment with withametelin (WTH) (A) or coagulansin A (CoA) (B) in the named cell lines. IC50 was determined using the pharmacoGx package in R.